16 reports

Major players in the generic pharmaceuticals market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.), Sun Pharmaceutical, Lupin Limited, Endo International Plc., Dr Reddy’s Laboratories, Apotex Holdings, Fresenius Kabi Ag, Aurbindo Pharma, Aspen Pharmacare, Sanofi, Cipla, Hikma Pharmaceuticals, Stada Arzneimittel,...

  • Generic Drug
  • World
  • United States
  • Middle East
  • APAC
  • Health Provider Density
  • Cause-Specific Mortality Rate

Major players in the generic pharmaceuticals market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.) and Sun Pharmaceutical. The global generic pharmaceuticals market is expected to grow from $233.66 billion in 2020 to $245.6 billion in 2021 at a compound annual growth rate (CAGR) of 5.1%. The growth...

  • Generic Drug
  • World
  • United States
  • APAC
  • Health Provider Density
  • Cause-Specific Mortality Rate

Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing...

  • Generic Drug
  • World
  • Chronic Disease Prevalence
  • Diabetes Prevalence

Forecasts by Drug Class (Bronchodilators, Combination Drugs, Corticosteroids, Decongestant Sprays, Antihistamines, Others), by Indication (Asthma, Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, Others), by Patient Demographics (Adult Patient, Paediatric Patient, Geriatric Patient), by End-user (Homecare, Hospitals, Specialty...

  • Cough And Cold
  • Nasal Drug Delivery
  • Generic Drug
  • APAC
  • World
  • Europe
  • Latin America
  • Generic Drugs Market Share

United States Generic Drugs Market By Segment (Generic, Branded), Therapeutic Application, Company Analysis & Forecast Generics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosage, quality, effect, intended use and side effects. In the...

  • Generic Drug
  • United States
  • Generics Use
  • Health Expenditure

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D...

  • Research And Development
  • Generic Drug
  • Anti-Infective
  • Parenteral Nutrition
  • In-Store Retail
  • Chronic Disease
  • Pharmacy
  • Cardiology
  • World

Generics in Brazil - Market Summary, Competitive Analysis and Forecast to 2025 Summary Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains...

  • Pharmaceutical
  • Generic Drug
  • Brazil
  • Generics Use
  • Consumer Price Index

Generics in Turkey - Market Summary, Competitive Analysis and Forecast to 2025 Summary Generics in Turkey industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the...

  • Pharmaceutical
  • Generic Drug
  • Medical Device
  • Turkey
  • Consumer Price Index
  • Generic Drugs Market Share

Global Generics

307 350 273

Global Generics Summary Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and...

  • Pharmaceutical
  • Generic Drug
  • World
  • Generic Drugs Market Share
  • Biologics Sales

Generics in Spain Summary Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and...

  • Pharmaceutical
  • Generic Drug
  • Spain
  • Consumer Price Index
  • Generics Use

United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. United States Generic Drugs Market is so huge that nearly 80% of dispensing prescriptions accounts generic drugs. According to FDA in the United States 9 out of 10 prescriptions filled are for generic drugs. Most of the physicians and hospitals...

  • Generic Drug
  • United States
  • Chronic Disease Prevalence
  • Drug Approval

United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. United States Generic Drugs Market is so huge that nearly 80% of dispensing prescriptions accounts generic drugs. According to FDA in the United States 9 out of 10 prescriptions filled are for generic drugs. Most of the physicians and hospitals...

  • Generic Drug
  • United States
  • Chronic Disease Prevalence
  • Drug Approval

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global generics industry. Over the years, the global generic drugs industry has grown strongly owing partly to the fact that the period for patent...

  • Pharmaceutical
  • Generic Drug
  • Drug Development
  • APAC
  • World
  • China
  • Japan
  • India
  • Generics Use
  • Generic Drugs Market Share

A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use. Generic drugs are less expensive because generic manufacturers don't have the investment costs of the developer of a new drug. New drugs are developed under patent protection. The...

  • Pharmaceutical
  • Generic Drug
  • United States
  • Drug Approval
  • Health Expenditure

This report on the inhalation and nasal spray generic drugs market studies the current and future prospects of the global market. Growing incidences of respiratory diseases such as asthma and COPD, increasing geriatric population, and increasing number of generic manufacturers is expected to accentuate the growth of inhalation and nasal spray...

  • Cough And Cold
  • Nasal Drug Delivery
  • Generic Drug
  • World

About Generic Drugs A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs...

  • Generic Drug
  • Pharmaceutical
  • Japan
  • Elderly Population
  • Generic Drugs Market Share